IP Library Granted Patent US 12,493,029
Granted Patent B2
US 12,493,029 · App. 17/761,398 · Granted Dec 9, 2025

Compositions, methods, and kits for the isolation of extracellular vesicles

Inventors: Johan Karl Olov Skog (Lincoln, MA); Olubode A. Ogunlusi (Framingham, MA); Robert Raymond Kitchen (Somerville, MA); Douglas Roberts (Waltham, MA); Wei Yu (Belmont, MA)
Assignee: Exosome Diagnostics, Inc.
G01N33/54333C12N15/1013
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,493,029
App. No.
17/761,398
Granted
Dec 9, 2025
Kind
B2
Abstract

The present disclosure relates to compositions, methods and kits for the isolation of extracellular vesicles. The compositions, methods and kits can comprise a high-density liquid reagent that facilitates the sequestration of extracellular vesicles bound to magnetic beads.

Claims (25)

1 . A method of isolating at least one microvesicle comprising at least one surface marker from at least one biological sample, the method comprising:

a) incubating the at least one biological sample with at least one particle that binds to the at least one surface marker under conditions sufficient to form at least one magnetic particle-microvesicle complex, wherein the at least one particle is a magnetic particle;

b) contacting the at least one biological sample comprising the at least one magnetic particle-microvesicle complex with at least one high-density matrix, wherein the at least one high-density matrix has a density that is equal to or greater than 1.22 g/ml; and

c) subjecting the at least one biological sample comprising the at least one magnetic particle-microvesicle complex and the at least one high-density matrix to a magnetic field such that the at least one magnetic particle-microvesicle complex is translocated through the high-density matrix, thereby isolating at least one microvesicle.

2 . A method of isolating at least one microvesicle comprising at least one surface marker from at least one biological sample, the method comprising:

a) incubating the at least one biological sample with at least one particle that binds to the at least one surface marker under conditions sufficient to form at least one particle-microvesicle complex;

b) contacting the at least one biological sample comprising the at least one particle-microvesicle complex with at least one high-density matrix, wherein the at least one high density-matrix has a density that is equal to or greater than 1.22 g/ml; and

c) subjecting the at least one biological sample comprising the at least one particle-microvesicle complex and the at least one high-density matrix to at least one force such that the at least one particle-microvesicle complex is translocated through the high-density matrix, thereby isolating at least one microvesicle.

3 . The method of claim 2 , wherein the force is a magnetic force, gravitational force, centrifugal force, pressure or any combination thereof.

4 . The method of claim 1 , wherein the at least one high-density matrix comprises Optiprep, sucrose, Ficoll, Histopaque, Percoll, or any combination thereof.

5 . The method of claim 1 , wherein the at least one particle comprises at least one antibody or at least one antibody fragment that binds to the at least one surface marker.

6 . The method of claim 5 , wherein the at least one antibody or at least one antibody fragment is coupled to the at least one particle by perfectly base-paired sense and anti-sense oligonucleotides, a partially double-stranded oligonucleotide, a double-stranded oligonucleotide, a photocleavable linker moiety, a disulfide bond, at least one peptide, or any combination thereof.

7 . The method of claim 1 , wherein the particle comprises at least one affinity molecule that binds to the at least one surface marker.

8 . The method of claim 7 , wherein the at least one affinity molecule comprises at least one antibody fragment, at least one aptamer, at least one aptamer analog, at least one lectin, at least one molecularly imprinted polymer, or any combination thereof.

9 . The method of claim 1 , wherein the at least one particle comprises a ferromagnetic bead.

10 . The method of claim 1 , wherein steps (b) and (c) are performed in at least one well of a microwell plate.

11 . The method of claim 10 , wherein the microwell plate is a 6-well plate, a 12-well plate, a 48-well plate, a 96-well plate, a 384-well plate, or a 1536-well plate.

12 . The method of claim 1 , further comprising:

d) removing the biological sample and the high-density matrix from the at least one particle-microvesicle complex.

13 . The method of claim 1 , further comprising:

d) removing at least 80% of the biological sample and at least 80% of the high-density matrix from the at least one particle-microvesicle complex.

14 . The method of claim 1 , wherein removing the biological sample and the high-density matrix from the at least one particle-microvesicle complex comprises aspiration.

15 . The method of claim 1 , wherein the method results in isolation of at least 80% of microvesicles in the biological sample that comprise the at least one surface marker.

16 . The method of claim 1 , wherein the biological sample comprises blood, serum, plasma, urine cerebrospinal fluid or any combination thereof.

17 . The method of claim 1 , further comprising extracting at least one nucleic acid, at least one carbohydrate molecule, at least one lipid, at least one protein, or any combination thereof from the isolated at least one microvesicle.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2026
From: EXOSOME DIAGNOSTICS, INC.
To: EXACT SCIENCES CORPORATION
Reel/Frame 075391/0617 →
RELEASE OF SECURITY INTEREST Recorded Jan 13, 2026
From: ORC SPV LLC
To: EXOSOME DIAGNOSTICS, INC.
Reel/Frame 073452/0001 →
SECURITY INTEREST Recorded Sep 29, 2025
From: EXOSOME DIAGNOSTICS, INC.
To: ORC SPV LLC
Reel/Frame 072403/0019 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PCT APPLICATION US2020051525 PREVIOUSLY RECORDED AT REEL: 64704 FRAME: 506. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Recorded Aug 5, 2024
From: SKOG, JOHAN KARL OLOV; OGUNLUSI, OLUBODE A.; KITCHEN, ROBERT RAYMOND; ROBERTS, DOUGLAS; YU, WEI
To: EXOSOME DIAGNOSTICS, INC.
Reel/Frame 068319/0008 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2023
From: SKOG, JOHAN KARL OLOV; OGUNLUSI, OLUBODE A.; KITCHEN, ROBERT RAYMOND; ROBERTS, DOUGLAS; YU, WEI
To: EXOSOME DIAGNOSTICS, INC.
Reel/Frame 064704/0506 →
Continuity (2)
Provisional Application 62902058 · Sep 18, 2019
Related Publication 20220412971A1 · Dec 29, 2022
References Cited (12)
US 20070254351A1 · Abrignani et al. · 2007 [cited by applicant]
US 20130203061A1 · Kuslich · 2013 [cited by examiner]
US 20160186262A1 · Johnson · 2016 [cited by examiner]
US 20190250147A1 · Vallabhajosyula · 2019 [cited by examiner]
WO WO2014107571A1 · 2014 [cited by applicant]
WO WO2016007755A1 · 2016 [cited by applicant]
WO WO2017197399A1 · 2017 [cited by applicant]
WO WO2021055770A2 · 2021 [cited by applicant]
Chen et al., Advances in exosomes technology, Clinica Chimica Acta, 2019, pp. 14-19, vol. 493. [cited by applicant]
Koliha et al., A novel multiplex bead-based platform highlights the diversity of extracellular vesicles, Journal of Extracellular Vesicles, 2016, 15 pages. http://dx.doi.org/10.3402/jev.v5.29975\. [cited by applicant]
Li et al., Progress in Exosome Isolation Techniques, Theranostics, 2017, pp. 789-804, vol. 7, No. 3. doi:10.7150/thno.18133. [cited by applicant]
Zocco & Zarovni, Chapter 22: Extraction and Analysis of Extracellular Vesicle-Associated miRNAs Following Antibody-Based Extracellular Vesicle Capture from Plasma Samples, Plant Genotyping, Methods in Molecular Biology,… [cited by applicant]